COLUMBIA, Md., Feb. 17, 2010 (GLOBE NEWSWIRE) -- Martek Biosciences Corporation (Nasdaq:MATK) announced today that it intends to hold an Investor Day on Friday, March 5, 2010 in New York, NY. The event will begin at 9:00 a.m. EST and will conclude at approximately 11:00 a.m. EST, and will be focused primarily on an overview of the company's technology platform and new product pipeline, followed by a question and answer session.
Attendance in person is by pre-registration only. For more information on attending, please contact Kyle Stults, Director of Investor Relations at (410) 740-0081. A live webcast of the event can be accessed by visiting http://investors.martek.com starting at 9:00 a.m. EST on March 5. A replay of the webcast will be available following the conclusion of the live presentation and will be accessible for 30 days.
Martek Biosciences Corporation is a leader in the innovation and development of DHA omega-3 products that promote health and wellness through every stage of life. The Company produces life'sDHA, a sustainable and vegetarian source of DHA omega-3, for use in foods, beverages, infant formula and supplements, and life'sARA (arachidonic acid), an omega-6 fatty acid, for use in infant formula. For more information on Martek Biosciences, visit http://www.martek.com/.